AOP-208

N/A

Report date: 2024/02/28 17:56:14
NME

Base Information

Drug NameAOP-208
Drug Alias NameAOP-208LB-208
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1b (5-HT1b) receptor antagonists
TargetsSerotonin 1b (5-HT1b) receptor
Therapy Area/IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLeukos Biotech SL
China Registration ClassN/A

Develop Information

Active CompaniesAOP Health GroupAop Orphan Pharmaceuticals Ag
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A